In 1921 was created Cleveland Clinic, which is appeared as Corporate Investor. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Cleveland.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Cleveland Clinic, startups are often financed by Venrock, UPMC, Threshold. The meaningful sponsors for the fund in investment in the same round are MemorialCare Innovation Fund, JumpStart Inc., Atrium Health. In the next rounds fund is usually obtained by Wellcome Trust, Venrock, U.S. Venture Partners (USVP).
Among the most popular portfolio startups of the fund, we may highlight SironRX Therapeutics, Hemex Health, Xealth. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Information Technology, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Speaking about the real fund results, this Corporate Investor is 9 percentage points more often commits exit comparing to other organizations. This Cleveland Clinic works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2011. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2014.
This organization was formed by George Washington Crile, William Edgar. The overall number of key employees were 6.
Fund Name | Location |
Arcadia Partners | England, London, United Kingdom |
Climate Change Capital | England, London, United Kingdom |
EJAM Capital Partners | China, Guangdong, Panyu |
Extraprise | Boston, Massachusetts, United States |
GuideOne Insurance | Des Moines, Iowa, United States |
Guoguang Electric Company Ltd | China, Japan, Kagoshima Prefecture |
Intellitext | Budapest, Hungary |
IntercontinentalExchange | Atlanta, Georgia, United States |
Quiet Capital | Seattle, United States, Washington |
Railways Pension Scheme | England, London, United Kingdom |
Sier Capital Partners | New York, New York, United States |
Super Brain Fund | - |
TGV Partners | - |
The Impact Investment Fund Pty Ltd. | Australia, Melbourne, Victoria |
TOMS Capital Investment Management | New York, New York, United States |
Tongxinlin Touzi | Beijing, Beijing, China |
Value Asset Management | - |
Yi Capital | Beijing, Beijing, China |
Zhongwei Jijin | China, Jiading District |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
XII Medical | $45M | 21 Aug 2024 | Union City, California, United States | ||
Neuro Therapia | $12M | 06 Aug 2024 | Ohio, Illinois, United States | ||
Enspire DBS Therapy | $17M | 01 Aug 2023 | Cleveland, Ohio, United States | ||
Centerline Biomedical | $33M | 27 Jun 2022 | Cleveland, Ohio, United States | ||
XII Medical | $30M | 05 May 2022 | Union City, California, United States | ||
Xealth | $25M | 05 Oct 2021 | Seattle, Washington, United States | ||
Neuro Therapia | $8M | 22 Sep 2020 | Illinois, United States | ||
Xealth | $3M | 20 Jun 2019 | Seattle, Washington, United States | ||
Hemex Health | $1M | 19 Dec 2017 | Portland, Oregon, United States |
– Xealth, the leader in enabling digital health at scale, announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health.
– Seven additional health systems – Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health and Stanford Health Care – join existing health system investors Atrium Health, Cleveland Clinic, Froedtert & MCW Health Network, MemorialCare Innovation Fund, Providence and UPMC.
– This brings the company’s total funding to date to $52.6 million.
– Use of digital therapeutics and remote patient monitoring is accelerating as they help fill a necessary role in extending care options for patients.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
XII Medical | $45M | 21 Aug 2024 | Union City, California, United States | ||
Neuro Therapia | $12M | 06 Aug 2024 | Ohio, Illinois, United States | ||
Enspire DBS Therapy | $17M | 01 Aug 2023 | Cleveland, Ohio, United States | ||
Centerline Biomedical | $33M | 27 Jun 2022 | Cleveland, Ohio, United States | ||
XII Medical | $30M | 05 May 2022 | Union City, California, United States | ||
Xealth | $25M | 05 Oct 2021 | Seattle, Washington, United States | ||
Neuro Therapia | $8M | 22 Sep 2020 | Illinois, United States | ||
Xealth | $3M | 20 Jun 2019 | Seattle, Washington, United States | ||
Hemex Health | $1M | 19 Dec 2017 | Portland, Oregon, United States |